The goal of current examine was to re-evaluate the impacts of elevated Fe(III) stress on anaerobic ammonium oxidation (anammox) process. The outcomes indicated that long-term low focus Fe(III) (5 and 10 mg/L) publicity considerably improved the nitrogen elimination effectivity of anammox process, whereas excessive focus Fe(III) (50 and 100 mg/L) considerably deteriorated the reactor efficiency.
Batch assays confirmed that the precise anammox exercise, heme c content material and hydrazine dehydrogenase exercise have been considerably elevated and decreased below low and excessive focus Fe(III) publicity, respectively, indicating an enhancement and inhibition of anammox exercise. Moreover, the presence of excessive focus Fe(III) considerably shifted the anammox community construction.
Ca. Brocadia was the predominant anammox genus, whose abundance decreased from 14.26% to 8.13% as Fe(III) focus elevated from 0 to 100 mg/L. In comparability, the abundance of denitrifiers progressively elevated from 3.70% to 6.68% with growing Fe(III) focus. These recommended that completely different functional micro organism differed of their responses to Fe(III) stress.
Furthermore, long-term Fe(III) publicity considerably up-regulated the abundances of genes related to nitrogen metabolism and Fe(III) discount. Overall, the obtained findings are anticipated to advances our understanding of the responses of anammox process to elevated Fe(III) stress.
Schizophrenia is a fancy mind dysfunction with genetic and environmental elements contributing to its etiology. Complement C4 genes are schizophrenia susceptibility loci and are activated in response to infections and intestine microbiome imbalances. We hypothesize that C4 genetic susceptibility predisposes people to neuropathological results from pathogen exposures or a microbiome in dysbiosis. In 214 people with schizophrenia and 123 non-psychiatric controls, we examined C4 gene copy quantity and haplotype teams for associations with schizophrenia and microbial plasma biomarkers.
C4A copy quantity and haplotypes containing HERV-Okay insertions (C4A-long; C4AL-C4AL) conferred elevated odds ratios for schizophrenia diagnoses (OR 1.58-2.56, p < 0.0001), whereas C4B-short (C4BS) haplogroups conferred decreased odds. In schizophrenia solely, LBP and CMV IgG ranges have been inversely correlated with C4A and C4S copy numbers, respectively.
C4 haplogroups have been related to altered scores of cognitive functioning in each circumstances and controls and with psychiatric symptom scores in schizophrenia. Our findings hyperlink complement C4 genes with a susceptibility to infections and a dysbiotic microbiome in schizophrenia. These outcomes assist immune system mechanisms by which gene-environmental interactions could also be operative in schizophrenia.
A biofoundry workflow for the identification of genetic determinants of microbial progress inhibition
Biofoundries combine high-throughput software program and {hardware} platforms with artificial biology approaches to allow the design, execution and analyses of large-scale experiments. The distinctive and highly effective mixture of laboratory infrastructure and experience in molecular biology and automation programming, present versatile assets for a variety of workflows and analysis areas.
Here, we reveal the applicability of biofoundries to molecular microbiology, describing the event and utility of automated workflows to establish the genetic foundation of progress inhibition of the plant pathogen Streptomyces scabies by a Pseudomonas pressure remoted from a potato area. Combining transposon mutagenesis with automated high-throughput antagonistic assays, the workflow accelerated the screening of 2880 mutants to correlate progress inhibition with a biosynthetic gene cluster inside 2 weeks.
Several present applied sciences allow brief genomic alterations together with producing indels and brief nucleotide variants, nonetheless, engineering extra important genomic adjustments is tougher due to diminished effectivity and precision. Here, we developed RecT Editor by way of Designer-Cas9-Initiated Targeting (REDIT), which leverages phage single-stranded DNA-annealing proteins (SSAP) RecT for mammalian genome engineering.
Relative to Cas9-mediated homology-directed restore (HDR), REDIT yielded up to a 5-fold enhance of effectivity to insert kilobase-scale exogenous sequences at outlined genomic areas. We validated our REDIT strategy utilizing completely different codecs and lengths of knock-in templates.
We additional demonstrated that REDIT instruments utilizing Cas9 nickase have environment friendly gene-editing actions and diminished off-target errors, measured utilizing a mix of focused sequencing, genome-wide indel, and insertion mapping assays. Our experiments inhibiting restore enzyme actions recommended that REDIT has the potential to overcome limitations of endogenous DNA restore steps. Finally, our REDIT methodology is relevant throughout cell varieties together with human stem cells, and is generalizable to completely different Cas9 enzymes.
The destiny and long-term poisonous results of NiO nanoparticles at environmental focus in constructed wetland: Enzyme exercise, microbial property, metabolic pathway and functional genes
Although the potential threats of metallic oxide nanoparticles (MNPs) to constructed wetland (CW) have been broadly reported, restricted info is accessible relating to the long-term affect of nickel oxide nanoparticles (NiO NPs) on CWs on the environmentally related concentrations. Here, we comprehensively elucidated the responses within the therapy efficiency, enzyme actions, microbial properties, metabolic pathways and functional genes of CWs to persistent publicity of NiO NPs (0.1 and 1 mg/L) for 120 days, with a quantitative evaluation on the destiny and migration of NiO NPs inside CWs. Nitrogen elimination evidently declined below the long-term publicity to NiO NPs. Besides, NiO NPs induced a deterioration in phosphorus elimination, however step by step restored over time.
 Recombinant Hepatitis C virus Genome polyprotein |
|
MBS7037960-01mg |
MyBiosource |
0.1mg |
EUR 2630 |
Recombinant Hepatitis C virus Genome polyprotein |
|
MBS7037960-5x01mg |
MyBiosource |
5x0.1mg |
EUR 11785 |
Recombinant Hepatitis C virus Genome polyprotein |
|
MBS7037961-002mg |
MyBiosource |
0.02mg |
EUR 1670 |
Recombinant Hepatitis C virus Genome polyprotein |
|
MBS7037961-01mg |
MyBiosource |
0.1mg |
EUR 2630 |
Recombinant Hepatitis C virus Genome polyprotein |
|
MBS7037961-5x01mg |
MyBiosource |
5x0.1mg |
EUR 11785 |
Recombinant Hepatitis C virus Genome polyprotein |
|
MBS7037962-002mg |
MyBiosource |
0.02mg |
EUR 1400 |
Recombinant Hepatitis C virus Genome polyprotein |
|
MBS7037962-01mg |
MyBiosource |
0.1mg |
EUR 2365 |
Recombinant Hepatitis C virus Genome polyprotein |
|
MBS7037962-5x01mg |
MyBiosource |
5x0.1mg |
EUR 10600 |
 Hepatitis C virus genotype 1a Genome polyprotein |
|
1-CSB-EP333180HFD |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10ug
- 50ug
- 100ug
- 200ug
- 500ug
- 1MG
|
|
|
|
Description: Recombinant Hepatitis C virus genotype 1a Genome polyprotein,partial expressed in E.coli |
Hepatitis C virus genotype 1a Genome polyprotein |
|
1-CSB-MP333180HFD |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: Recombinant Hepatitis C virus genotype 1a Genome polyprotein,partial expressed in Mammalian cell |
 Hepatitis C virus genotype 1b Genome polyprotein |
|
1-CSB-YP530838HVQ(A3) |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10ug
- 50ug
- 100ug
- 200ug
- 500ug
- 1MG
|
|
|
|
Description: Recombinant Hepatitis C virus genotype 1b Genome polyprotein,partial expressed in Yeast |
Hepatitis C virus genotype 1b Genome polyprotein |
|
1-CSB-YP530838HVQ(A4) |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10ug
- 50ug
- 100ug
- 200ug
- 500ug
- 1MG
|
|
|
|
Description: Recombinant Hepatitis C virus genotype 1b Genome polyprotein,partial expressed in Yeast |
 Recombinant Human hepatitis A virus genotype IA Genome polyprotein |
|
MBS1163442-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 1130 |
Recombinant Human hepatitis A virus genotype IA Genome polyprotein |
|
MBS1163442-005mgEColi |
MyBiosource |
0.05mg(E-Coli) |
EUR 875 |
Recombinant Human hepatitis A virus genotype IA Genome polyprotein |
|
MBS1163442-005mgYeast |
MyBiosource |
0.05mg(Yeast) |
EUR 1010 |
Recombinant Human hepatitis A virus genotype IA Genome polyprotein |
|
MBS1163442-02mgEColi |
MyBiosource |
0.2mg(E-Coli) |
EUR 1130 |
Recombinant Human hepatitis A virus genotype IA Genome polyprotein |
|
MBS1163442-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 1245 |
 Recombinant Hepatitis C virus Genome polyprotein,partial |
|
AP72393 |
SAB |
each |
Ask for price |
|
|
 Recombinant Hepatitis C virus Genome polyprotein, partial |
|
MBS1087197-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 1200 |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|
MBS1087197-1mgYeast |
MyBiosource |
1mg(Yeast) |
EUR 1710 |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|
MBS1197403-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 1200 |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|
MBS1197403-1mgYeast |
MyBiosource |
1mg(Yeast) |
EUR 1710 |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|
MBS1041882-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|
MBS1018847-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 1200 |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|
MBS1018847-1mgYeast |
MyBiosource |
1mg(Yeast) |
EUR 1710 |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|
MBS1017822-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 1200 |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|
MBS1017822-1mgYeast |
MyBiosource |
1mg(Yeast) |
EUR 1710 |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|
MBS7083727-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|
MBS7060004-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|
MBS7060367-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|
MBS7060967-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Recombinant Human hepatitis A virus genotype IIA Genome polyprotein |
|
MBS1279215-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Recombinant Simian hepatitis A virus genotype VI Genome polyprotein |
|
MBS1044911-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 870 |
Recombinant Simian hepatitis A virus genotype VI Genome polyprotein |
|
MBS1044911-005mgEColi |
MyBiosource |
0.05mg(E-Coli) |
EUR 480 |
Recombinant Simian hepatitis A virus genotype VI Genome polyprotein |
|
MBS1044911-005mgYeast |
MyBiosource |
0.05mg(Yeast) |
EUR 700 |
Recombinant Simian hepatitis A virus genotype VI Genome polyprotein |
|
MBS1044911-02mgEColi |
MyBiosource |
0.2mg(E-Coli) |
EUR 625 |
Recombinant Simian hepatitis A virus genotype VI Genome polyprotein |
|
MBS1044911-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 690 |
 Recombinant Simian hepatitis A virus genotype V Genome polyprotein |
|
MBS1013869-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Recombinant Human hepatitis A virus genotype IIIA Genome polyprotein |
|
MBS1431010-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 1080 |
Recombinant Human hepatitis A virus genotype IIIA Genome polyprotein |
|
MBS1431010-005mgEColi |
MyBiosource |
0.05mg(E-Coli) |
EUR 755 |
Recombinant Human hepatitis A virus genotype IIIA Genome polyprotein |
|
MBS1431010-005mgYeast |
MyBiosource |
0.05mg(Yeast) |
EUR 915 |
Recombinant Human hepatitis A virus genotype IIIA Genome polyprotein |
|
MBS1431010-02mgEColi |
MyBiosource |
0.2mg(E-Coli) |
EUR 1010 |
Recombinant Human hepatitis A virus genotype IIIA Genome polyprotein |
|
MBS1431010-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 1110 |
 Duck hepatitis A virus polyprotein Polyclonal Antibody |
|
MBS9237550-01mL |
MyBiosource |
0.1mL |
EUR 415 |
Duck hepatitis A virus polyprotein Polyclonal Antibody |
|
MBS9237550-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1841 |
 Recombinant Hepatitis C virus genotype 4a Genome polyprotein |
|
MBS1079380-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1085 |
Recombinant Hepatitis C virus genotype 4a Genome polyprotein |
|
MBS1079380-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 675 |
Recombinant Hepatitis C virus genotype 4a Genome polyprotein |
|
MBS1079380-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 840 |
Recombinant Hepatitis C virus genotype 4a Genome polyprotein |
|
MBS1079380-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 790 |
Recombinant Hepatitis C virus genotype 4a Genome polyprotein |
|
MBS1079380-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 980 |
 Recombinant Hepatitis GB virus B Genome polyprotein, partial |
|
MBS7085832-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Recombinant Human hepatitis A virus genotype IB Genome polyprotein, partial |
|
MBS1220473-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Recombinant Human hepatitis A virus genotype IA Genome polyprotein, partial |
|
MBS1207515-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Recombinant Human hepatitis A virus genotype IIB Genome polyprotein, partial |
|
MBS1307563-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Human hepatitis A virus genotype IA Genome polyprotein, partial |
|
MBS1255162-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Human hepatitis A virus genotype IA Genome polyprotein, partial |
|
MBS1251717-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Human hepatitis A virus genotype IB Genome polyprotein, partial |
|
MBS1057291-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Recombinant Simian hepatitis A virus genotype IV Genome polyprotein, partial |
|
MBS1031233-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Human hepatitis A virus genotype IA Genome polyprotein, partial |
|
MBS1479676-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Recombinant Human hepatitis A virus genotype IIIB Genome polyprotein, partial |
|
MBS1010551-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|
CSB-EP333180HFD |
Cusabio |
3004 mg |
Ask for price |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|
CSB-EP333180HFD-20ug |
Cusabio |
20ug |
Ask for price |
|
|
|
Description: 192-325aa |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|
CSB-MP333180HFD |
Cusabio |
4998 mg |
Ask for price |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|
CSB-MP333180HFD-20ug |
Cusabio |
20ug |
Ask for price |
|
|
|
Description: 192-325aa |
 Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
CSB-YP530838HVQ(A3) |
Cusabio |
6465 mg |
Ask for price |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
CSB-YP530838HVQ(A3)-20ug |
Cusabio |
20ug |
Ask for price |
|
|
|
Description: 2-177aa |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
CSB-YP530838HVQ(A4) |
Cusabio |
6466 mg |
Ask for price |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
CSB-YP530838HVQ(A4)-20ug |
Cusabio |
20ug |
Ask for price |
|
|
|
Description: 192-358aa |
 Recombinant Hepatitis C virus genotype 1b Genome polyprotein,partial |
|
AP73727 |
SAB |
each |
Ask for price |
|
|
Recombinant Hepatitis C virus genotype 1b Genome polyprotein,partial |
|
AP73728 |
SAB |
each |
Ask for price |
|
|
 Recombinant Hepatitis C virus genotype 6d Genome polyprotein, partial |
|
MBS1226183-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 2505 |
Recombinant Hepatitis C virus genotype 6d Genome polyprotein, partial |
|
MBS1226183-1mgYeast |
MyBiosource |
1mg(Yeast) |
EUR 2980 |
 Recombinant Hepatitis C virus genotype 6h Genome polyprotein, partial |
|
MBS1239793-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 2505 |
Recombinant Hepatitis C virus genotype 6h Genome polyprotein, partial |
|
MBS1239793-1mgYeast |
MyBiosource |
1mg(Yeast) |
EUR 2980 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
MBS1238854-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 2505 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
MBS1238854-1mgYeast |
MyBiosource |
1mg(Yeast) |
EUR 2980 |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|
MBS1169939-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 2505 |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|
MBS1169939-1mgYeast |
MyBiosource |
1mg(Yeast) |
EUR 2980 |
 Recombinant Hepatitis C virus genotype 2a Genome polyprotein, partial |
|
MBS1185658-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 2505 |
Recombinant Hepatitis C virus genotype 2a Genome polyprotein, partial |
|
MBS1185658-1mgYeast |
MyBiosource |
1mg(Yeast) |
EUR 2980 |
 Recombinant Hepatitis C virus genotype 6b Genome polyprotein, partial |
|
MBS1161053-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 2505 |
Recombinant Hepatitis C virus genotype 6b Genome polyprotein, partial |
|
MBS1161053-1mgYeast |
MyBiosource |
1mg(Yeast) |
EUR 2980 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
MBS1134475-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
MBS1081858-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 2505 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
MBS1081858-1mgYeast |
MyBiosource |
1mg(Yeast) |
EUR 2980 |
 Recombinant Hepatitis C virus genotype 6a Genome polyprotein, partial |
|
MBS1111818-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 2505 |
Recombinant Hepatitis C virus genotype 6a Genome polyprotein, partial |
|
MBS1111818-1mgYeast |
MyBiosource |
1mg(Yeast) |
EUR 2980 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
MBS1261568-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 2505 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
MBS1261568-1mgYeast |
MyBiosource |
1mg(Yeast) |
EUR 2980 |
 Recombinant Hepatitis C virus genotype 2b Genome polyprotein, partial |
|
MBS1066487-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 2505 |
Recombinant Hepatitis C virus genotype 2b Genome polyprotein, partial |
|
MBS1066487-1mgYeast |
MyBiosource |
1mg(Yeast) |
EUR 2980 |
 Recombinant Hepatitis C virus genotype 6k Genome polyprotein, partial |
|
MBS1072352-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 2505 |
Recombinant Hepatitis C virus genotype 6k Genome polyprotein, partial |
|
MBS1072352-1mgYeast |
MyBiosource |
1mg(Yeast) |
EUR 2980 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
MBS1004937-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 2505 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
MBS1004937-1mgYeast |
MyBiosource |
1mg(Yeast) |
EUR 2980 |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|
MBS1005431-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 375 |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|
MBS1005431-002mgMammalianCell |
MyBiosource |
0.02mg(Mammalian-Cell) |
EUR 425 |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|
MBS1005431-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 635 |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|
MBS1005431-01mgMammalianCell |
MyBiosource |
0.1mg(Mammalian-Cell) |
EUR 1015 |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|
MBS1005431-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 1925 |
 Recombinant Hepatitis C virus genotype 5a Genome polyprotein, partial |
|
MBS1027168-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 2505 |
Recombinant Hepatitis C virus genotype 5a Genome polyprotein, partial |
|
MBS1027168-1mgYeast |
MyBiosource |
1mg(Yeast) |
EUR 2980 |
Recombinant Hepatitis C virus genotype 5a Genome polyprotein, partial |
|
MBS1001699-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 2505 |
Recombinant Hepatitis C virus genotype 5a Genome polyprotein, partial |
|
MBS1001699-1mgYeast |
MyBiosource |
1mg(Yeast) |
EUR 2980 |
 Recombinant Hepatitis C virus genotype 3a Genome polyprotein, partial |
|
MBS7091930-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Hepatitis C virus genotype 3a Genome polyprotein, partial |
|
MBS7091931-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Recombinant Hepatitis C virus genotype 2c Genome polyprotein, partial |
|
MBS7085011-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Recombinant Hepatitis C virus genotype 6g Genome polyprotein, partial |
|
MBS7085811-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Recombinant Hepatitis C virus genotype 3k Genome polyprotein, partial |
|
MBS7086666-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Hepatitis C virus genotype 6a Genome polyprotein, partial |
|
MBS7081854-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Recombinant Hepatitis C virus genotype 1c Genome polyprotein, partial |
|
MBS7090883-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Recombinant Hepatitis C virus genotype 3b Genome polyprotein, partial |
|
MBS7091092-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
MBS7097404-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Hepatitis C virus genotype 2a Genome polyprotein, partial |
|
MBS7097910-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
MBS7102489-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Recombinant Hepatitis C virus genotype 2k Genome polyprotein, partial |
|
MBS7099413-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Hepatitis C virus genotype 1c Genome polyprotein, partial |
|
MBS7094099-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Hepatitis C virus genotype 2b Genome polyprotein, partial |
|
MBS7099644-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
MBS9423307-002mg |
MyBiosource |
0.02mg |
EUR 505 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
MBS9423307-01mg |
MyBiosource |
0.1mg |
EUR 895 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
MBS9423307-05mg |
MyBiosource |
0.5mg |
EUR 1975 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
MBS9423307-5x05mg |
MyBiosource |
5x0.5mg |
EUR 8735 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
MBS9423308-002mg |
MyBiosource |
0.02mg |
EUR 505 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
MBS9423308-01mg |
MyBiosource |
0.1mg |
EUR 895 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
MBS9423308-05mg |
MyBiosource |
0.5mg |
EUR 1975 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|
MBS9423308-5x05mg |
MyBiosource |
5x0.5mg |
EUR 8735 |
 (HCV) Genome polyprotein) Recombinant Hepatitis C virus genotype 1a (isolate 1) (HCV) Genome polyprotein |
|
MBS9420854-002mg |
MyBiosource |
0.02mg |
EUR 460 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) (HCV) Genome polyprotein |
|
MBS9420854-01mg |
MyBiosource |
0.1mg |
EUR 795 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) (HCV) Genome polyprotein |
|
MBS9420854-1mg |
MyBiosource |
1mg |
EUR 2525 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) (HCV) Genome polyprotein |
|
MBS9420854-5x1mg |
MyBiosource |
5x1mg |
EUR 11205 |
 Hepatitis C Genome polyprotein |
|
1-CSB-RP184674Ba |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10ug
- 50ug
- 100ug
- 200ug
- 500ug
- 1MG
|
|
|
|
Description: Recombinant Hepatitis C Genome polyprotein expressed in E.coli |
 Recombinant Hepatitis C virus H77 Genome polyprotein protein, C-His Tag |
|
MBS156843-005mg |
MyBiosource |
0.05mg |
EUR 345 |
Recombinant Hepatitis C virus H77 Genome polyprotein protein, C-His Tag |
|
MBS156843-01mg |
MyBiosource |
0.1mg |
EUR 450 |
Recombinant Hepatitis C virus H77 Genome polyprotein protein, C-His Tag |
|
MBS156843-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1710 |
 (HCV) Genome polyprotein) Recombinant Hepatitis C virus genotype 1b (strain HC-J4) (HCV) Genome polyprotein |
|
MBS969708-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 420 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) (HCV) Genome polyprotein |
|
MBS969708-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 695 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) (HCV) Genome polyprotein |
|
MBS969708-05mgYeast |
MyBiosource |
0.5mg(Yeast) |
EUR 1505 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) (HCV) Genome polyprotein |
|
MBS969708-5x05mgYeast |
MyBiosource |
5x0.5mg(Yeast) |
EUR 6565 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) (HCV) Genome polyprotein |
|
MBS969709-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 420 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) (HCV) Genome polyprotein |
|
MBS969709-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 695 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) (HCV) Genome polyprotein |
|
MBS969709-05mgYeast |
MyBiosource |
0.5mg(Yeast) |
EUR 1505 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) (HCV) Genome polyprotein |
|
MBS969709-5x05mgYeast |
MyBiosource |
5x0.5mg(Yeast) |
EUR 6565 |
 (HCV) Genome polyprotein(E1),partial) Recombinant Hepatitis C virus genotype 1a (isolate 1) (HCV) Genome polyprotein(E1),partial |
|
AP70969 |
SAB |
1mg |
EUR 2826 |
|
|
 Recombinant Hepatitis C Genome polyprotein |
|
CSB-RP184674Ba |
Cusabio |
5430 mg |
Ask for price |
Recombinant Hepatitis C Genome polyprotein |
|
CSB-RP184674Ba-20ug |
Cusabio |
20ug |
Ask for price |
|
|
|
Description: 1-631aa |
 Equine Rhinitis A Virus Genome Polyprotein Antibody |
|
abx345840-100g |
Abbexa |
100 µg |
Ask for price |
Equine Rhinitis A Virus Genome Polyprotein Antibody |
|
abx345840-20g |
Abbexa |
20 µg |
EUR 250 |
Equine Rhinitis A Virus Genome Polyprotein Antibody |
|
abx345840-50g |
Abbexa |
50 µg |
EUR 350 |
) Hepatitis E virus genotype 1 Non-structural polyprotein pORF1 (ORF1) |
|
1-CSB-EP327230HGE |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10ug
- 50ug
- 100ug
- 200ug
- 500ug
- 1MG
|
|
|
|
Description: Recombinant Hepatitis E virus genotype 1 Non-structural polyprotein pORF1(ORF1),partial expressed in E.coli |
 Recombinant Hepatitis C virus polyprotein |
|
MBS1265554-002mg |
MyBiosource |
0.02mg |
EUR 375 |
Recombinant Hepatitis C virus polyprotein |
|
MBS1265554-01mg |
MyBiosource |
0.1mg |
EUR 635 |
Recombinant Hepatitis C virus polyprotein |
|
MBS1265554-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2630 |
The actions of dehydrogenase (DHA), phosphatase (PST), urease (URE), ammonia oxygenase (AMO) and nitrate reductase (NAR) have been inhibited to some extent below NiO NPs stress. Furthermore, NiO NPs publicity diminished bacterial variety, shifted microbial composition and clearly inhibited the transcription of the ammonia oxidizing and denitrifying functional genes. The outcomes of nickel mass steadiness indicated that the main elimination mechanism of NiO NPs in CWs was by means of substrate adsorption and vegetation uptake. Thus, the ecological impacts of extended NiO NPs publicity at environmental concentrations shouldn’t be uncared for.
